Literature DB >> 6208306

Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line.

A Weiss, J D Stobo.   

Abstract

The association between T3 and the T cell antigen receptor was examined using the T3 bearing T cell leukemic line Jurkat. A monoclonal antibody, C305, was produced, which reacted with idiotypic-like determinants expressed on Jurkat. The molecule with which this antibody reacted was a disulfide-linked heterodimer of 90 kD, composed of polypeptides of 42 and 54 kD. Thus, C305 reacted with a molecule with characteristics of the putative T cell antigen receptor described by others. A series of mutants of Jurkat, induced with ethyl methane sulfonate or radiation, was selected for T3 or antigen receptor negativity. In every instance, there was a concomitant loss of both T3 and the antigen receptor as assessed by quantitative absorption, indirect immunofluorescence, and antibody plus complement-mediated cytotoxicity. The absence of antigen receptor molecules was confirmed on diagonal gels, excluding the possibility that conformational changes of the antigen receptor on such T3-negative mutants were responsible for the failure of such mutants to react with C305. Moreover, in a mutant that expressed a marked decrease in the level of T3 expression, there was a comparable decrease in the expression of antigen receptor determinants. These results suggest that there is an obligate requirement for the coexpression of T3 and the T cell antigen receptor. Furthermore, attempts to activate such mutants with the lectin phytohemagglutinin suggested that the expression of T3 and/or the antigen receptor was required for activation of these cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208306      PMCID: PMC2187507          DOI: 10.1084/jem.160.5.1284

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Selective suppression of reactivity to rat histocompatibility antigens by hybridoma antibodies.

Authors:  T J McKearn; M Sarmiento; A Weiss; F P Stuart; F W Fitch
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

2.  The use of glucose oxidase as a generator of H 2 O 2 in the enzymatic radioiodination of components of cell surfaces.

Authors:  I Schenkein; M Levy; J W Uhr
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cellular origin and interactions involved in gamma-interferon production induced by OKt3 monoclonal antibody.

Authors:  T W Chang; D Testa; P C Kung; L Perry; H J Dreskin; G Goldstein
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

5.  Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.

Authors:  P Kavathas; F H Bach; R DeMars
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

6.  Cell-free translation of the mRNAs for the heavy and light chains of HLA-A and HLA-B antigens.

Authors:  H L Ploegh; L E Cannon; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

7.  Mouse pre-B cells synthesize and secrete mu heavy chains but not light chains.

Authors:  D Levitt; M D Cooper
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

8.  Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody.

Authors:  J P Allison; B W McIntyre; D Bloch
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

9.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.

Authors:  S C Meuer; K A Fitzgerald; R E Hussey; J C Hodgdon; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  171 in total

1.  A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT.

Authors:  G M Ku; D Yablonski; E Manser; L Lim; A Weiss
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.

Authors:  Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Yingge Liu; Mogjiborahman Salek; Novella Rapini; Aaron D Schenone; Patrizia Saccucci; Lucia G Delogu; Federica Angelini; Maria Luisa Manca Bitti; Christian Schmedt; Andrew C Chan; Oreste Acuto; Nunzio Bottini
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

3.  The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.

Authors:  J A DeCaprio; Y Furukawa; F Ajchenbaum; J D Griffin; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

4.  Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec.

Authors:  Michael G Tomlinson; Lawrence P Kane; Jennifer Su; Theresa A Kadlecek; Marianne N Mollenauer; Arthur Weiss
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production.

Authors:  G A Koretzky; J Picus; T Schultz; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Human cytotoxic T-lymphocyte recognition of an HLA-A3 gene product expressed on murine L cells: the only human gene product required on the target cells for lysis is the class I heavy chain.

Authors:  E P Cowan; J E Coligan; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Authors:  Nancy Dumais; Marie-Eve Paré; Simon Mercier; Salim Bounou; Susan J Marriot; Benoit Barbeau; Michel J Tremblay
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.

Authors:  S Sano; Y Matsui; S Itami; K Yoshikawa
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

Review 9.  Organization of proximal signal initiation at the TCR:CD3 complex.

Authors:  Clifford S Guy; Dario A A Vignali
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

10.  Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.

Authors:  Mark R Karver; Divya Krishnamurthy; Nunzio Bottini; Amy M Barrios
Journal:  J Inorg Biochem       Date:  2009-12-28       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.